ONE STEP Benzodiazepines (BZO) Test

Dénomination commerciale

ONE STEP Benzodiazepines (BZO) Test

06936155807000

B-06936155807000

Numéro de référence/catalogue

ITP06006-TC40

GS1

IVDD — Général

Législation applicable

IVDD [Directive 98/79/CE relative aux dispositifs médicaux de diagnostic in vitro]

Statut

Sur le marché

Quantité

1

Description complémentaire du produit

The One Step Benzodiazepines (BZO) Test is a rapid, immunochromatographic assay for the detection of benzodiazepines in human urine. The test is used to screen urine for the presence of oxazepam, the main metabolite of benzodiazepines. The test is intended for use by healthcare professionals only. This test provides only a preliminary analytical test result. A more specific alternate chemical method must be used in order to obtain a confirmed analytical result. Gas chromatography/mass spectrophotometry (GC/MS) is the preferred confirmatory method. Clinical considerations and professional judgment should be applied to any drug of abuse test result, particularly when preliminary positive results are indicated. Benzodiazepines are pharmaceutically used for anxiolytic, hypnotic, anticonvulsant and muscle relaxant effects, and many benzodiazepines are excreted as oxazepam and its glucuronide in urine. The test is a qualitative visual screening immunoassay based on a competitive binding principle. Benzodiazepines or their metabolites in the urine compete with drug conjugate immobilized on the membrane for limited antibody binding sites. A negative specimen produces two colored bands, while a positive specimen produces only one control band. The control band indicates that sufficient sample volume has been added and that the reagents are functioning properly.

URL des informations complémentaires

Aucune URL d'informations complémentaires renseignée par le fabricant.

Dimensions cliniques

Aucune dimension clinique enregistrée pour ce dispositif.

Nomenclature européenne des dispositifs médicaux — la classification produit UE attribuée à ce dispositif.

• W0102160504BENZODIAZEPINES - RT & POC

3 avertissements enregistrés — faire défiler le panneau pour tout voir.

• CW011

  For professional in vitro diagnostic use only. This product is designed for detection of oxazepam in human urine only and provides a preliminary qualitative screening result only. Positive results should be confirmed using an alternate method, preferably GC/MS, and clinical considerations and professional judgment should be applied. The test is not suggested for determining the quantitative benzodiazepines level in urine and does not indicate the level of intoxication or monitor drug levels. Avoid cross-contamination of urine samples by using a new urine specimen cup for each sample, and do not interpret results after 8 minutes.
• CW010

  Read and follow the package insert carefully before use.
• CW032

  Do not use the kit beyond the expiration date printed on the outside of the foil pouch.